
Phosphorus Depletion Is An Investment Opportunity
As CO2 levels rise, soil phosphorus becomes less available for certain key crops like paddy rice. This means more will have to be applied. If we have endless amounts of phosphorus then this isn't an issue, phosphorus can be applied as liberally as we like.
We Have About 100 Years Of Phosphorus Left On Earth
That will be a pretty hard limit when it's reached. It will be difficult to replace the source of phosphorus when the phosphate mines run out, so recapturing as much as possible is our best strategy. The reserves confirmed in Norway in 2023 have nearly doubled our known global supply, but this is still a finite resource. What's more, the mining isn't simple and clean; even with expanded reserves we all want clean air and water, which phosphate mining doesn't support. Strip mining always destroys the surface landscape and ecosystems which is bad, for sure; with mining phosphates we further release heavy metals and radioactive materials that add more risks. Florida and the Netherlands are not rushing to exploit their reserves because of the environmental impact of mining phosphates. In Florida, a large phosphate reserve sits on the Florida Aquifer which really exemplifies the problem.
A river polluted by mud and waste dumped from the Kef Eddou mine, Tunisia. Footprints of animals ... More indicate that they graze in the area. Phosphate Mining pollutes waterways, leaving local residents and animals unable to drink the contaminated water.
Prior to the Norway phosphate deposit discovery, 70% of the world's phosphate reserves were in Morocco and the Western Sahara. Some of the world recognizes this territory as Moroccan now, but there is still a war there, and the Polisario Front broke the ceasefire in 2020 after Moroccan provocation. Will these lucrative phosphate reserves lead to more resource driven conflict? Will Algeria seize the opportunity to support separatist forces and profit from the instability, as we so famously have seen nations do with critical minerals in Congo? Will parts of Norway look like Nauru, a formerly lush tropical paradise stripped of its phosphate rock, and now a barren, impoverished cautionary tale?
A phosphate mining site in Nauru, 1997.
Bacteria And Fungi
Once phosphorus is applied to a field, it will be available to plants for a short time before reacting with other elements in the soil. There's a goldilocks phenomena with pH for phosphorus; if the soil is too acidic or too basic, the phosphorus will bind with other elements and become largely unavailable to the plants. A pH range of 6-7 is ideal for absorption. This shows the difficulty of handling other factors that could impact phosphorus use indirectly. Complicated problems will often require multifaceted solutions.
Some bacteria and fungi make phosphorus in the soil available to plants. Phosphate solubilizing microorganisms (PSMs) are able to break down insoluble forms of phosphorus and make it available to plants as a form that can be easily absorbed. These phosphate-solubilizing microorganisms can reduce fertilizer use by half while producing the same, or higher, crop yields.
There is a lack of standardization, and the scalability of this method will need attention. Do lingering questions about this biotechnology disqualify it? No, it means that this is an emerging technology with huge growth potential. This is the time to invest and research.
Gene Editing
If we can't add endless phosphates to soil, and if bacteria and fungi can only do so much, then why don't we make plants that are better at absorbing phosphorus? It's being worked on. The japonica variety of rice has been successfully gene-edited by Indian researchers to absorb 20% more phosphate, an advancement that will be applied to the indica variety; these are the two most popular types of rice is Asia. Given its role as a staple food for much of the world, without adapting rice to climate change we will need to use ever larger amounts of our limited phosphorus, or face food insecurity.
If this sort of advancement can me made with rice, can gene editing be done to other staple crops to increase their absorptivity?
Raising rice and ducks together has been shown to improve phosphorus absorption.
Wastewater Recycling
There are a few ways to go about this, but the basic idea is to remove phosphorus from wastewater and reuse it. Each individual discharges 2 grams of phosphorus, daily. Recovery can be done with thermal, biological or chemical means which have their respective pros and cons, but ultimately these processes can recover maybe 40-90+% of the otherwise wasted phosphorus.
Different phosphorus recovery methods have their respective efficiencies and advantages. Several ... More could be presently adopted at scale.
Phosphorus mining should be regarded as our last option after recovery and mitigation. With every finite good, we'll have to worry about scarcity and the associated price increases, and this is all while we have any phosphorus left to fight over. Investing in the infrastructure to recover phosphorus and beneficial microorganism cultivation are the superior, greener investment opportunities that are still largely untapped.
When problems like the finite supply of phosphorus have been identified and publicized 100 years ago, how can we reasonably pretend to be unaware? Why, beyond collective failure of global political leadership, do we not have answers to questions that were asked back before the Great Depression? Having been aware of this phosphorus problem for a century, and with perhaps two centuries left before we're completely out, how much longer should we wait before mass adaptation of the solutions, even if they require substantial investment now? Why doesn't every wastewater facility apply some method of recapture?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
3 hours ago
- Forbes
The Prototype: Bringing Advanced Semiconductor Manufacturing Back To The U.S.
In this week's edition of The Prototype, we look at a federal program to bring advanced semiconductor R&D to Florida, a quantum computing milestone for biotech, a new way to get forever chemicals out of the water supply and more. You can sign up to get The Prototype in your inbox here . Florida Semiconductor Engine T he tech sector drives the U.S. economy, which in turn is undergirded by the semiconductor chips that power servers, computers, phones and more. Even though these chips are mostly designed domestically, they're not made in America: Nearly 90% are imported. That's an issue that Tawny Olore wants to help fix. She's the CEO of the Florida Semiconductor Engine, one of 10 regional networks backed by a two-yer, $15 million grant from the National Science Foundation. Half of that money is going towards research and development, for which it has five major projects. These include developing improved hardware security, designing 6G chips for the next generation of mobile internet and a project to build cryogenic, superconducting chips for AI and other forms of advanced computing. The other half of the spend is geared towards workforce development programs to ensure that there are people with the skills needed for the jobs the Engine hopes to bring back to the U.S. For example, it helped to develop an Associate's Degree for semiconductor engineering at Valencia College. The program, which is enrolling its first students this Fall, will train students to work in cleanrooms and operate the delicate equipment used to make chips. 'That's really important and shouldn't be diminished by the research and development projects that are so cool,' Olore said. 'You've got to have people there to be able to fill those jobs.' Stay tuned. IBM ran its simulation of mRNA structures on its Heron quantum processor. IBM L ast month, IBM rolled out its framework for building a 'fault-tolerant' quantum computer–one that can solve practical problems with low rates of error caused by the physics of its operations–by 2029. One major part of that is understanding what business problems exist that quantum computing can play a role in solving, Jamie Garcia, director of algorithms and partnerships at the company, told me. One potential: drug development. IBM has been working with biotech company Moderna since 2023, finding new techniques to predict the structures of messenger RNA (mRNA), which is at the core of Moderna's Covid vaccine and a number of other therapies it's developing. Figuring out how to use mRNA, which helps tell your body which proteins to make, is a complicated process. There are countless ways to code mRNA to make the same protein. For the Covid vaccine, for example, there are about 10^623 different possibilities. But the code is not enough–the order in which that code is arranged also affects how the final mRNA molecule is physically structured, which affects things like how durable it is and how large or small a dose might be–that's crucial for what arrangement will work best as a drug. 'That is sort of a combinatorial optimization issue that blows up really big, really fast,' Garcia said. For conventional computers, it would take centuries to solve them with brute force–even using AI models–because the hardware has to consider each possibility one at a time. That forces programmers to use shortcuts by simplifying the math to rougher approximations. A quantum computer, by contrast, can tackle portions of the problem in parallel–which makes for ultimately better calculations. Using quantum algorithms based on ones IBM had previously developed for financial problems, the two companies were able to successfully predict the structure of an mRNA sequence that was about 60 nucleotides long, which is at the upper limit of what a conventional computer can do. While that's much smaller than the sequences used for drugs, Garcia said that IBM's quantum computer will be able to predict bigger and bigger structures as the company builds out its capabilities. 'We're really excited about these results,' she said. 'And I think we're just going to keep finding the next generation of algorithms to really start checking the box when it comes to RNA problems.' DISCOVERY OF THE WEEK: NEW MATERIAL CLEANS FOREVER CHEMICALS FROM WATER Researchers at the University of Utah have invented a new material that can clean Perfluorooctanoic acid (PFOA) from water sources. PFOA belongs to the family of 'forever chemicals' that can contaminate soil and water without breaking down, and exposure to it can cause cancer. The new zirconium-based material not only attracts and absorbs PFOA, it also lights up when it does so, letting any engineers know that the forever chemical is present in a body of water. The cleaning material is also reusable–PFOA can be removed with conventional processes. This combination 'makes it a versatile and practical solution for water treatment and environmental monitoring,' lead author Rana Dalapati said in a statement. FINAL FRONTIER: SOUTH KOREA PLANS A MOON BASE In a public hearing earlier this week, South Korea's space agency laid out a roadmap for its exploration of space, The Korea Times reported. The agency is making its own plans to establish a permanent moon base by the year 2045. To help it get there, it will develop its own capabilities to launch and land humans on the lunar surface by 2040. WHAT ELSE I WROTE THIS WEEK In my other newsletter, InnovationRx, Amy Feldman and I looked at Sarepta's showdown with the FDA over its gene therapy for Duchenne Muscular Dystrophy, the FDA's new top drug regulator, a biotech company's strategy to fight cancer, a startup's therapy chatbot, and more. SCIENCE AND TECH TIDBITS Astronomers found an object in the outer solar system that seems to be moving in sync with Neptune. About 56 miles in diameter, it circles the Sun once for every ten times it takes the eighth planet. The orbits are in sync at this ratio despite being millions of miles apart, something that hasn't been seen before by scientists. Researchers at the University of California, Riverside have discovered a way to repair DNA that's been damaged by environmental stress, which could one day lead to prevention of afflictions like arthritis and inflammatory bowel disease. Around 10 million people live with HTLV-1 infection, which can lead to inflammatory diseases or even forms of cancer, but it currently has no treatments or vaccines. However, new research with mice suggests that existing HIV drugs could help prevent both transmission and disease. Street noise is one of the most annoying parts of city life, but Swiss scientists may have a solution: they've invented a mineral foam that can dampen street noise and is easier to install, since it's about four times thinner than conventional sound absorbers. PRO SCIENCE TIP: GET YOUR 7,000 STEPS A DAY It's long been a common rule of thumb to aim for 10,000 steps a day for optimal health, which can be a challenge for those who are stuck at their desks for work all day. But a new study suggests that you can get the same benefit with nearly one-third fewer steps. In a review of 57 different studies conducted in over ten countries, the researchers' analysis found walking around 7,000 steps a day reduced the risk of dementia and type two diabetes, and had other benefits as well. Which is not to say that getting 10,000 steps a day is bad–but 7,000 seems to represent an inflection point: the benefits accumulate quickly up to that point. Beyond it, the health benefits are more modest. WHAT'S ENTERTAINING ME THIS WEEK This month marks the 100th anniversary of the 'Scopes Monkey Trial'—in which schoolteacher John T. Scopes was found guilty of violating a Tennessee law that prohibited teaching the theory of evolution. So I kicked back and watched Inherit the Wind , Stanley Kramer's adaptation of the play of the same name, which is a fictionalized version of the Scopes trial. It's an absolutely mesmerizing courtroom drama that's still painfully relevant today, featuring a thunderous performance by Spencer Tracy as defense attorney Henry Drummond. It's streaming on Amazon Prime right now. MORE FROM FORBES Forbes South Park's Creators Are Now Billionaires By Matt Craig Forbes How Jeffrey Epstein Got So Rich By Giacomo Tognini Forbes Chicago's Kumiko Named World's Best Bar At 2025 Spirited Awards By Michael Solomon


Forbes
5 hours ago
- Forbes
The New World Food Prize Laureate Uses Microorganisms To Save Soils
A soybean field in Formosa do Rio Preto. (Photo by NELSON ALMEIDA / AFP via Getty Images) When Mariangela Hungria, the winner of the 2025 World Food Prize, started college for microbiology, agriculture had just seen the Green Revolution, and scientists were focused on using artificial fertilizers to feed a growing population. But she didn't think that was the way only forward. Dr. Hungria knew that microorganisms could help achieve nitrogen fixation and better soil-health. She knew that biological fertilizers can help feed the world. In other words, she's been a champion of regenerative agriculture before that term was even widely used! The World Food Prize is a prestigious honor that recognizes her lifetime of work that's literally changed agronomics from the ground up. But as a young scientist in the 1970s and 1980s, she faced significant pushback from the mostly male scientific establishment that believed chemicals were the only option. 'It's not easy to start your career when everybody says that you are not going to have a future,' Dr. Hungria says on the podcast. To prove that microorganisms had a vital role not just on smallholder farms or organic operations but within large-scale, high-yield agriculture, 'I had to change the way I was doing research.' She began involving farmers as collaborators in the research process. As with her commitment to regenerative agriculture, she didn't set out to be a trailblazer: She was just doing things the way she thought was right. 'People talk about participative science, and I say, 'I was doing this a long time ago. I just didn't know!'' she says. 'Every research that I did, it was because a farmer came to me to talk about something. It was because a farmer came [to me] or I met a farmer in the field, and he told me what he wanted and what was happening, and that gave me ideas to do my work.' And just as she set out to prove from the beginning, she has demonstrated that the positive results that come from regenerative practices can be scaled up to fit any size farm. 'The same technology, the same bacteria, that helps the small farmers also helps the big farmers,' she says. 'We use the same in 1 hectare or in 100,000 hectares, so that's really wonderful to work with something that's usable for all.' Dr. Hungria identifies several barriers she continues to face in her work, and I think there are a few takeaways that the entire good food movement can learn from: 1. The regenerative agriculture movement cannot be overshadowed by competition and corporate interests. Even when faced with data on the success of biological fertilizers, some farmers are still skeptical due to aggressive marketing from chemical fertilizer manufacturers, Dr. Hungria says. And occasionally, companies that do adopt biological fertilizers seem more interested in widely planted crops that are more profitable, rather than culturally relevant crops in local communities. As Dr. Hungria explained, feeding the world can't be a competition—which is also why she makes all her research and solutions available publicly for free. 2. We have to think creatively about how to earn people's attention. Dr. Hungria believes strongly in the power of scientific communication. But she's frustrated, she says, by the experience of spending time preparing a concise online video explaining nuance and data—only for the video's view count to be dwarfed by influencers spreading misinformation or changing the subject away from agriculture entirely. 3. The future of science has to be collaborative, inclusive, and egalitarian. Dr. Hungria is candid about the challenges she faced and continues to face as a woman and a mother in a male-dominated scientific world. 'I had lots of problems because there were not many women,' she says. 'And worse, I was a woman working with biologicals that nobody believed in, and with two daughters. I was very improbable to succeed in my career.' But Dr. Hungria did succeed—and she's worked for her entire career to rebuild a scientific field that's less competitive and more participatory, collaborative, and focused on listening to others and appreciating diversity of ideas. This is the kind of approach we truly need to transform the food system! She says, 'I really think that the science of the future will be a female science.' I hope Dr. Hungria's work will inspire future generations of regenerative farmers, microbiologists, food advocates, and citizen eaters—and I also hope it'll inspire us right now, in this generation, to take the action we desperately need to nurture our soils, nourish our bodies, and keep our planet alive.


Medscape
7 hours ago
- Medscape
EMA OKs Oral Treatment for Postnatal Depression
The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on zuranolone (Zurzuvae, Biogen Netherlands BV), the first oral drug to treat postpartum depression in adults. Marketing authorization was granted in recognition of clinical trial results showing a reduction in postpartum depressive symptoms after 2 weeks' treatment. Zuranolone is a neuroactive steroid that enhances the activity of the neurotransmitter gamma-aminobutyric acid (GABA). It is thought to exert antidepressant effects by enhancing GABAergic inhibition. In a multicenter, randomized, double-blind, placebo-controlled study, zuranolone at a 50 mg dose was given for 14 days to women who met the Diagnostic and Statistical Manual of Mental Disorders criteria for a major depressive episode of postpartum depression and whose symptoms started in the third trimester or within 4 weeks of delivery. Compared with placebo, the active group demonstrated significantly greater symptom improvement on days 3,15 (the primary endpoint), and 45, using the standard 17-item Hamilton rating scale for depression. The FDA approved the drug in August 2023, at which time it was the first oral treatment for postpartum depression, with previous therapies requiring intravenous dosing. It is available in 20 mg, 25 mg, and 30 mg capsules. The most common side effects are somnolence, dizziness, confusion, trouble walking, and sedation. Patients are advised to avoid alcohol and not to drive, operate machinery, or undertake other dangerous activities until at least 12 hours after taking each dose during the 14-day treatment course. There may also be an increased risk of suicidal thoughts and actions in people 24 years of age and younger. Animal studies have suggested a possible risk of teratogenic effects, so women who may become pregnant are advised to use effective contraception during treatment and for 1 week after the final dose, and to alert their healthcare provider should they become pregnant during treatment. The EMA said that detailed recommendations will be described in the summary of product characteristics, which will be published on the EMA website in all official European Union languages after the marketing authorization has been granted by the European Commission. Perinatal Mental Healthcare 'in Its Infancy' In Western countries, postpartum depression is estimated to affect between 10% and 15% of women during the first year after birth , with substantial differences in rates depending on socioeconomic factors such as marital status, educational level, social support, spouse care, violence, gestational age, breast feeding, child mortality, financial difficulties, partnership, life stress, smoking, alcohol intake, and living conditions. Common symptoms include feelings of desperation, sadness, anxiety, irritability, and isolation, as well as nausea, changes in sleep and eating habits, decreased libido, crying spells, mental lability, thoughts of hurting oneself and/or the infant, and suicidal ideation. The condition can wreak havoc on women's mental health as well as that of their partners. It can impair the parental relationship, the mother-child bond, and the emotional and cognitive growth of infants, with potential long-term effects. Postnatal depression may occur alongside post-traumatic stress disorder following stressful or traumatic childbirth experiences . Yet a review published in Frontiers in Psychiatry last year suggested that fewer than half of countries in the World Health Organization (WHO) European region had policies specifically on perinatal mental health, leading its authors to conclude that "perinatal mental health care is in its infancy in most WHO European countries."